Startups
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need.
Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Virogin is designing a more potent oncolytic virus, expressing optimized payloads to enhance the systemic antitumor immunity in relapsed/refractory cancers.
Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market.
Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Virogin is designing a more potent oncolytic virus, expressing optimized payloads to enhance the systemic antitumor immunity in relapsed/refractory cancers.
Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market.
Overview
Location
Canada, British Columbia, Richmond
Employees
11-50
Total raised
$62M
Founded date
2015
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about Virogin Biotech
When was Virogin Biotech founded?
Virogin Biotech was founded in 2015.
How much funding has Virogin Biotech raised?
Virogin Biotech has raised $62M in total across 1 funding round.
Is Virogin Biotech still active?
Yes, Virogin Biotech is active; its latest activity on Parsers VC dates from Aug 28, 2026.